Mental Health DailyResearch. Evidence. Perspective.Published research on Drugs.
A 2026 FAERS pharmacovigilance study of 28,938 dystonia reports found the strongest reporting signal for metoclopramide, while antipsychotics dominated the high-volume psychiatric medication…
Read articleA 2026 target-trial emulation involving 102,361 U.S. veterans with type 2 diabetes found no increased suicidality risk after starting semaglutide vs. sodium-glucose cotransporter-2 inhibitor…
Read articleA Global Burden of Disease analysis estimated that U.S. age-standardized substance-use disorder disability-adjusted life-year rates rose 213.5% from 1990 to 2019, with opioid use disorders p…
Read articleAn 11-person case series tested delayed-release apple cider vinegar capsules in young adults who had gained weight while taking psychotropic medications, and metabolic markers carried more s…
Read articleA 2026 BRFSS analysis involving 4,071 U.S. adults who used cannabis and either smoked cigarettes, vaped nicotine, or did both found a strong modality match: people who vaped tobacco were muc…
Read articleAustralian coronial data show that fatal poisonings involving new psychoactive stimulants and hallucinogens were rarely single-drug events. In 70 toxicology-confirmed deaths from 2007 throug…
Read articleA 2026 rat study found that 21 days of late-adolescent tetrahydrocannabinol (THC) exposure produced adult anxiety-like behavior in the elevated plus maze and weaker novel object recognition …
Read article
